The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Xenetix 300mg I/ml Solution for injection, polypropylene bag


Main Information

Trade NameXenetix 300mg I/ml Solution for injection, polypropylene bag
Active SubstancesIodine
Dosage FormSolution for injection
Licence HolderGuerbet
Licence NumberPA0686/002/004

Group Information

ATC CodeV08AB Watersoluble, nephrotropic, low osmolar X-ray contrast media
V08AB11 iobitridol


License statusAuthorised
Licence Issued10/09/2010
Legal statusProduct subject to Restricted Prescription (C)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back